Furthermore, in human ovarian and endometrial cancers, the VISTA expression on cancer cells suppressed T-cell proliferation and cytokine production in vitro, and anti-VISTA treatment extended the survival of tumor-bearing mice [38]. This evidence concerns the gene VSIR and endometrial cancer.